Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1997 Oct;89(10):673–678.

Modulation of lipid profile by fish oil and garlic combination.

N C Morcos 1
PMCID: PMC2608252  PMID: 9347681

Abstract

Fish consumption has been shown to influence epidemiology of heart disease, and garlic has been shown to influence triglyceride levels. This study was undertaken to evaluate the effect of fish oil and garlic combinations as a dietary supplement on the lipid subfractions. Forty consecutive subjects with lipid profile abnormalities were enrolled in a single-blind, placebo-controlled crossover study. Each subject received placebo for 1 month and fish oil (1800 mg of eicosapentanoic acid [EPA] + 1200 mg of docosahexanoic acid) with garlic powder (1200 mg) capsules daily for 1 month. Lipid fractionation was performed prior to study initiation, after the placebo period, and after the intervention period. Subjects all had cholesterol levels > 200. Subjects were instructed to maintain their usual diets. Supplementation for 1 month resulted in an 11% decrease in cholesterol, a 34% decrease in triglyceride, and a 10% decrease in low-density lipoprotein (LDL) levels, as well as a 19% decrease in cholesterol/high-density lipoprotein (HDL) risk. Although not significant, there was a trend toward increase in HDL. There was no significant placebo effect. These results suggest that in addition to the known anticoagulant and antioxidant properties of both fish oil and garlic, the combination causes favorable shifts in the lipid subfractions within 1 month. Triglycerides are affected to the largest extent. The cholesterol lowering and improvement in lipid/HDL risk ratios suggests that these combinations may have antiatherosclerotic properties and may protect against the development of coronary artery disease.

Full text

PDF
673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdullah T. H., Kandil O., Elkadi A., Carter J. Garlic revisited: therapeutic for the major diseases of our times? J Natl Med Assoc. 1988 Apr;80(4):439–445. [PMC free article] [PubMed] [Google Scholar]
  2. Adler A. J., Holub B. J. Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr. 1997 Feb;65(2):445–450. doi: 10.1093/ajcn/65.2.445. [DOI] [PubMed] [Google Scholar]
  3. Auer W., Eiber A., Hertkorn E., Hoehfeld E., Koehrle U., Lorenz A., Mader F., Merx W., Otto G., Schmid-Otto B. Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Pract Suppl. 1990 Aug;69:3–6. [PubMed] [Google Scholar]
  4. Bairati I., Roy L., Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation. 1992 Mar;85(3):950–956. doi: 10.1161/01.cir.85.3.950. [DOI] [PubMed] [Google Scholar]
  5. Bang H. O., Dyerberg J., Nielsen A. B. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet. 1971 Jun 5;1(7710):1143–1145. doi: 10.1016/s0140-6736(71)91658-8. [DOI] [PubMed] [Google Scholar]
  6. Bendich A., Langseth L. The health effects of vitamin C supplementation: a review. J Am Coll Nutr. 1995 Apr;14(2):124–136. doi: 10.1080/07315724.1995.10718484. [DOI] [PubMed] [Google Scholar]
  7. Bordia A. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr. 1981 Oct;34(10):2100–2103. doi: 10.1093/ajcn/34.10.2100. [DOI] [PubMed] [Google Scholar]
  8. Brosche T., Platt D., Dorner H. The effect of a garlic preparation on the composition of plasma lipoproteins and erythrocyte membranes in geriatric subjects. Br J Clin Pract Suppl. 1990 Aug;69:12–19. [PubMed] [Google Scholar]
  9. Dyerberg J., Bang H. O., Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr. 1975 Sep;28(9):958–966. doi: 10.1093/ajcn/28.9.958. [DOI] [PubMed] [Google Scholar]
  10. Ernst E., Weihmayr T., Matrai A. Garlic and blood lipids. Br Med J (Clin Res Ed) 1985 Jul 13;291(6488):139–139. doi: 10.1136/bmj.291.6488.139-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gebhardt R. Inhibition of cholesterol biosynthesis by a water-soluble garlic extract in primary cultures of rat hepatocytes. Arzneimittelforschung. 1991 Aug;41(8):800–804. [PubMed] [Google Scholar]
  12. Gianturco S. H., Brown F. B., Gotto A. M., Jr, Bradley W. A. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J Lipid Res. 1982 Sep;23(7):984–993. [PubMed] [Google Scholar]
  13. Goodnight S. H. Mechanism of the antithrombotic effects of fish oil. Baillieres Clin Haematol. 1990 Jul;3(3):601–623. doi: 10.1016/s0950-3536(05)80021-6. [DOI] [PubMed] [Google Scholar]
  14. Grünwald J. Garlic and cardiovascular risk factors. Br J Clin Pharmacol. 1990 May;29(5):582–583. doi: 10.1111/j.1365-2125.1990.tb03685.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harenberg J., Giese C., Zimmermann R. Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis. 1988 Dec;74(3):247–249. doi: 10.1016/0021-9150(88)90244-4. [DOI] [PubMed] [Google Scholar]
  16. Harris W. S., Connor W. E., Illingworth D. R., Rothrock D. W., Foster D. M. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res. 1990 Sep;31(9):1549–1558. [PubMed] [Google Scholar]
  17. Harris W. S., Connor W. E., Inkeles S. B., Illingworth D. R. Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia. Metabolism. 1984 Nov;33(11):1016–1019. doi: 10.1016/0026-0495(84)90230-0. [DOI] [PubMed] [Google Scholar]
  18. Harris W. S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res. 1989 Jun;30(6):785–807. [PubMed] [Google Scholar]
  19. Herold P. M., Kinsella J. E. Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials. Am J Clin Nutr. 1986 Apr;43(4):566–598. doi: 10.1093/ajcn/43.4.566. [DOI] [PubMed] [Google Scholar]
  20. Huff M. W., Telford D. E. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein. Arteriosclerosis. 1989 Jan-Feb;9(1):58–66. doi: 10.1161/01.atv.9.1.58. [DOI] [PubMed] [Google Scholar]
  21. Jacques P. F., Sulsky S. I., Perrone G. A., Schaefer E. J. Ascorbic acid and plasma lipids. Epidemiology. 1994 Jan;5(1):19–26. doi: 10.1097/00001648-199401000-00005. [DOI] [PubMed] [Google Scholar]
  22. Jain A. K., Vargas R., Gotzkowsky S., McMahon F. G. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med. 1993 Jun;94(6):632–635. doi: 10.1016/0002-9343(93)90216-c. [DOI] [PubMed] [Google Scholar]
  23. Jung F., Jung E. M., Mrowietz C., Kiesewetter H., Wenzel E. Influence of garlic powder on cutaneous microcirculation: a randomised, placebo-controlled, double-blind, crossover study in apparently healthy subjects. Br J Clin Pract Suppl. 1990 Aug;69:30–35. [PubMed] [Google Scholar]
  24. Kauf E., Dawczynski H., Jahreis G., Janitzky E., Winnefeld K. Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital hypothyroidism. Biol Trace Elem Res. 1994 Mar;40(3):247–253. doi: 10.1007/BF02950797. [DOI] [PubMed] [Google Scholar]
  25. Keli S. O., Feskens E. J., Kromhout D. Fish consumption and risk of stroke. The Zutphen Study. Stroke. 1994 Feb;25(2):328–332. doi: 10.1161/01.str.25.2.328. [DOI] [PubMed] [Google Scholar]
  26. Kiesewetter H., Jung F., Jung E. M., Blume J., Mrowietz C., Birk A., Koscielny J., Wenzel E. Effects of garlic coated tablets in peripheral arterial occlusive disease. Clin Investig. 1993 May;71(5):383–386. doi: 10.1007/BF00186628. [DOI] [PubMed] [Google Scholar]
  27. Kiesewetter H., Jung F., Pindur G., Jung E. M., Mrowietz C., Wenzel E. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Clin Pharmacol Ther Toxicol. 1991 Apr;29(4):151–155. [PubMed] [Google Scholar]
  28. Kromhout D., Bosschieter E. B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985 May 9;312(19):1205–1209. doi: 10.1056/NEJM198505093121901. [DOI] [PubMed] [Google Scholar]
  29. Mader F. H. Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study. Arzneimittelforschung. 1990 Oct;40(10):1111–1116. [PubMed] [Google Scholar]
  30. Mansell P., Reckless J. P. Garlic. BMJ. 1991 Aug 17;303(6799):379–380. doi: 10.1136/bmj.303.6799.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mori T. A., Vandongen R., Beilin L. J., Burke V., Morris J., Ritchie J. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr. 1994 May;59(5):1060–1068. doi: 10.1093/ajcn/59.5.1060. [DOI] [PubMed] [Google Scholar]
  32. Mori T. A., Vandongen R., Mahanian F., Douglas A. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation. Metabolism. 1992 Oct;41(10):1059–1067. doi: 10.1016/0026-0495(92)90286-j. [DOI] [PubMed] [Google Scholar]
  33. Mori T. A., Vandongen R., Masarei J. R. Fish oil-induced changes in apolipoproteins in IDDM subjects. Diabetes Care. 1990 Jul;13(7):725–732. doi: 10.2337/diacare.13.7.725. [DOI] [PubMed] [Google Scholar]
  34. Mori T. A., Vandongen R., Masarei J. R., Rouse I. L., Dunbar D. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics. Metabolism. 1991 Mar;40(3):241–246. doi: 10.1016/0026-0495(91)90104-5. [DOI] [PubMed] [Google Scholar]
  35. Mori T. A., Vandongen R., Masarei J. R., Stanton K. G., Dunbar D. Dietary fish oils increase serum lipids in insulin-dependent diabetics compared with healthy controls. Metabolism. 1989 May;38(5):404–409. doi: 10.1016/0026-0495(89)90188-1. [DOI] [PubMed] [Google Scholar]
  36. Nestel P. J., Connor W. E., Reardon M. F., Connor S., Wong S., Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest. 1984 Jul;74(1):82–89. doi: 10.1172/JCI111422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nordöy A., Hatcher L. F., Ullmann D. L., Connor W. E. Individual effects of dietary saturated fatty acids and fish oil on plasma lipids and lipoproteins in normal men. Am J Clin Nutr. 1993 May;57(5):634–639. doi: 10.1093/ajcn/57.5.634. [DOI] [PubMed] [Google Scholar]
  38. Orekhov A. N., Tertov V. V., Sobenin I. A., Pivovarova E. M. Direct anti-atherosclerosis-related effects of garlic. Ann Med. 1995 Feb;27(1):63–65. doi: 10.3109/07853899509031938. [DOI] [PubMed] [Google Scholar]
  39. Packard C. J., Munro A., Lorimer A. R., Gotto A. M., Shepherd J. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest. 1984 Dec;74(6):2178–2192. doi: 10.1172/JCI111644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Phillipson B. E., Rothrock D. W., Connor W. E., Harris W. S., Illingworth D. R. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med. 1985 May 9;312(19):1210–1216. doi: 10.1056/NEJM198505093121902. [DOI] [PubMed] [Google Scholar]
  41. Rustan A. C., Nossen J. O., Christiansen E. N., Drevon C. A. Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res. 1988 Nov;29(11):1417–1426. [PubMed] [Google Scholar]
  42. Rustan A. C., Nossen J. O., Osmundsen H., Drevon C. A. Eicosapentaenoic acid inhibits cholesterol esterification in cultured parenchymal cells and isolated microsomes from rat liver. J Biol Chem. 1988 Jun 15;263(17):8126–8132. [PubMed] [Google Scholar]
  43. Sanders T. A., Sullivan D. R., Reeve J., Thompson G. R. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis. 1985 Sep-Oct;5(5):459–465. doi: 10.1161/01.atv.5.5.459. [DOI] [PubMed] [Google Scholar]
  44. Simons L. A., Balasubramaniam S., von Konigsmark M., Parfitt A., Simons J., Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis. 1995 Mar;113(2):219–225. doi: 10.1016/0021-9150(94)05449-s. [DOI] [PubMed] [Google Scholar]
  45. Sullivan D. R., Sanders T. A., Trayner I. M., Thompson G. R. Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil. Atherosclerosis. 1986 Aug;61(2):129–134. doi: 10.1016/0021-9150(86)90072-9. [DOI] [PubMed] [Google Scholar]
  46. Vorberg G., Schneider B. Therapy with garlic: results of a placebo-controlled, double-blind study. Br J Clin Pract Suppl. 1990 Aug;69:7–11. [PubMed] [Google Scholar]
  47. Wolf S., Reim M., Jung F. Effect of garlic on conjunctival vessels: a randomised, placebo-controlled, double-blind trial. Br J Clin Pract Suppl. 1990 Aug;69:36–39. [PubMed] [Google Scholar]
  48. Zimmermann W., Zimmermann B. Reduction in elevated blood lipids in hospitalised patients by a standardised garlic preparation. Br J Clin Pract Suppl. 1990 Aug;69:20–23. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES